190 related articles for article (PubMed ID: 26017316)
1. Management of Small Kidney Cancers in the New Millennium: Contemporary Trends and Outcomes in a Population-Based Cohort.
Huang WC; Atoria CL; Bjurlin M; Pinheiro LC; Russo P; Lowrance WT; Elkin EB
JAMA Surg; 2015 Jul; 150(7):664-72. PubMed ID: 26017316
[TBL] [Abstract][Full Text] [Related]
2. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
3. Renal and cardiovascular morbidity after partial or radical nephrectomy.
Miller DC; Schonlau M; Litwin MS; Lai J; Saigal CS;
Cancer; 2008 Feb; 112(3):511-20. PubMed ID: 18072263
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007.
Kowalczyk KJ; Choueiri TK; Hevelone ND; Trinh QD; Lipsitz SR; Nguyen PL; Lynch JH; Hu JC
BJU Int; 2013 Aug; 112(4):E273-80. PubMed ID: 23452093
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates.
Larcher A; Fossati N; Tian Z; Boehm K; Meskawi M; Valdivieso R; Trudeau V; Dell'Oglio P; Buffi N; Montorsi F; Guazzoni G; Sun M; Karakiewicz PI
Eur Urol; 2016 Apr; 69(4):676-682. PubMed ID: 26206408
[TBL] [Abstract][Full Text] [Related]
7. Evolving practice patterns for the management of small renal masses in the USA.
Yang G; Villalta JD; Meng MV; Whitson JM
BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer.
Tan HJ; Norton EC; Ye Z; Hafez KS; Gore JL; Miller DC
JAMA; 2012 Apr; 307(15):1629-35. PubMed ID: 22511691
[TBL] [Abstract][Full Text] [Related]
9. Impact of Perioperative Infection on Cancer Specific Survival after Nephrectomy for Renal Cell Carcinoma.
Tallman JE; Pearce SM; Kuchta K; Helfand BT; Eggener SE
J Urol; 2017 Nov; 198(5):1027-1032. PubMed ID: 28551443
[TBL] [Abstract][Full Text] [Related]
10. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
11. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
12. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management.
Sun M; Becker A; Tian Z; Roghmann F; Abdollah F; Larouche A; Karakiewicz PI; Trinh QD
Eur Urol; 2014 Jan; 65(1):235-41. PubMed ID: 23567066
[TBL] [Abstract][Full Text] [Related]
13. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses.
Whitson JM; Harris CR; Meng MV
BJU Int; 2012 Nov; 110(10):1438-43; discussion 1443. PubMed ID: 22639860
[TBL] [Abstract][Full Text] [Related]
14. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
[TBL] [Abstract][Full Text] [Related]
15. Contemporary, age-based trends in the incidence and management of patients with early-stage kidney cancer.
Tan HJ; Filson CP; Litwin MS
Urol Oncol; 2015 Jan; 33(1):21.e19-21.e26. PubMed ID: 25459360
[TBL] [Abstract][Full Text] [Related]
16. Use of surveillance imaging following treatment of small renal masses.
Kowalczyk KJ; Harbin AC; Choueiri TK; Hevelone ND; Lipsitz SR; Trinh QD; Tina Shih YC; Hu JC
J Urol; 2013 Nov; 190(5):1680-5. PubMed ID: 23764074
[TBL] [Abstract][Full Text] [Related]
17. Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time.
Bianchi M; Becker A; Hansen J; Trinh QD; Tian Z; Abdollah F; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
BJU Int; 2013 Jun; 111(8):E283-9. PubMed ID: 23714646
[TBL] [Abstract][Full Text] [Related]
18. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities and causes of death in the management of localized T1a kidney cancer.
Patel HD; Kates M; Pierorazio PM; Gorin MA; Jayram G; Ball MW; Hyams ES; Allaf ME
Int J Urol; 2014 Nov; 21(11):1086-92. PubMed ID: 24931430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
